Norethindrone Pregnancy and Breastfeeding Warnings

Norethindrone is also known as: Aygestin, Camila, Errin, Heather, Jencycla, Jolivette, Lyza, Nor-QD, Nora-Be, Norlyroc, Ortho Micronor

Norethindrone Pregnancy Warnings

Several reports have suggested the risk of hypospadias in the general population, approximately 5 to 8 per 1000 male births, may double with progestin exposure within the first four months of pregnancy. Although there are insufficient data to quantify the risk to exposed female fetuses, progestin use within the first trimester has been associated with mild virilization of the external genitalia.

Norethindrone has been assigned to pregnancy category X by the FDA. Animal studies have not been reported. Postmarketing human pregnancy data have revealed a possible association between first trimester progestin use and genitourinary anomalies in male and female fetuses. Norethindrone use is considered contraindicated during pregnancy.

Norethindrone Breastfeeding Warnings

Progestin excretion into human milk results in steroid levels in infant plasma of 1% to 6% of the levels of maternal plasma. Long-term follow-up studies have failed to document adverse developmental effects due to exposure to progestins in breast milk.

Progestins are excreted into human milk in small amounts. The effects in the nursing infant are unknown. Progestins, such as progesterone, are considered compatible with breast-feeding by the American Academy of Pediatrics.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide
(web2)